Table 3.
Identification of prognostic factors in EBER-/EBV DNA- patients by univariate and multivariate Cox regression analysisa
| Characteristic | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | |
| LRFFS | ||||
| Age (years) | 1.031 (0.959–1.109) | 0.407 | ||
| Gender | ||||
| Male | 1.000 (Reference) | |||
| Female | 0.441 (0.084–2.306) | 0.332 | ||
| Histology | ||||
| Keratinizing | 1.000 (Reference) | 1.000 (Reference) | ||
| Nonkeratinizing | 5.170 (1.124–23.792) | 0.035 | 2.480 (0.345–17.836) | 0.367 |
| T category | 0.983 (0.441–2.192) | 0.967 | ||
| N category | 1.375 (0.604–3.130) | 0.448 | ||
| III b | 1.579 (1.113–2.240) | 0.011 | 1.399 (0.917–2.134) | 0.120 |
| NI b | 1.174 (0.669–2.061) | 0.576 | ||
| OS | ||||
| Age (years) | 1.017 (0.923–1.120) | 0.740 | ||
| Gender | ||||
| Male | 1.000 (Reference) | |||
| Female | 0.333 (0.034–3.271) | 0.346 | ||
| Histology | ||||
| Keratinizing | 1.000 (Reference) | 1.000 (Reference) | ||
| Nonkeratinizing | 11.490 (1.104-119.619) | 0.041 | 6.060 (0.359–102.200) | 0.211 |
| T category | 0.861 (0.321–2.309) | 0.766 | ||
| N category | 1.979 (0.657–5.965) | 0.225 | ||
| III | 1.672 (1.057–2.645) | 0.028 | 1.389 (0.832–2.318) | 0.209 |
| NI | 1.288 (0.611–2.712) | 0.506 | ||
| aVariable exhibiting a P value less than 0.05 in the univariate Cox regression analysis were futher included in multivariate Cox regression analysis | ||||
| bThe calculation of III and NI is detailed elsewhere [18] | ||||
| EBER, EBV-encoded small ribonucleic acid; EBV, Epstein-Barr virus; III, immune inflammation index; LRFFS, locoregional failure-free survival; NI, nutrition index; OS, overall survival | ||||